Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online August 17, 2017.
Article Versions
- You are currently viewing a previous version of this article (August 17, 2017 - 04:35).
- View the most recent version of this article
Copyright & Usage
Copyright © 2017 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
Author Information
- Daniel Strakis Albrecht1,
- Marc David Normandin1,
- Sergey Shcherbinin2,
- Dustin W. Wooten1,
- Adam J. Schwarz3,
- Nicole R. Zurcher1,
- Vanessa N. Barth2,
- Nicolas J. Guehl1,
- Oluwaseun Johnson-Akeju1,
- Nazem Atassi1,
- Mattia Veronese4,
- Federico Turkheimer4,
- Jacob M. Hooker1 and
- Marco Luciano Loggia1
- 1 Massachusetts General Hospital / Harvard, United States;
- 2 Eli Lilly and Company, United States;
- 3 Eli Lilly & Co;
- 4 King's College London, United Kingdom
- For correspondence or reprints contact: Marco Luciano. Loggia, Massachusetts General Hospital / Harvard, 149 Thirteenth St, Room 2301, Charlestown, MA 02129, United States. E-mail: marco@nmr.mgh.harvard.edu
Statistics from Altmetric.com
Cited By...
Article usage
In this issue
Jump to section
Related Articles
Cited By...
- Study protocol for a phase II, double-blind, randomised controlled trial of cannabidiol (CBD) compared with placebo for reduction of brain neuroinflammation in adults with chronic low back pain
- Multimodal Investigation of Neuroinflammation in Aviremic Patients With HIV on Antiretroviral Therapy and HIV Elite Controllers
- Moving Toward Multicenter Therapeutic Trials in Amyotrophic Lateral Sclerosis: Feasibility of Data Pooling Using Different Translocator Protein PET Radioligands
- Head-to-Head Comparison of 11C-PBR28 and 18F-GE180 for Quantification of the Translocator Protein in the Human Brain